| 1 |
Ahn_J_2020 |
Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea |
Ahn, Jin Young; Sohn, Yujin; Lee, Su Hwan; Cho, Yunsuk; Hyun, Jong Hoon; Baek, Yae Jee; Jeong, Su Jin; Kim, Jung Ho; Ku, Nam Su; Yeom, Joon-Sup; Roh, Juhye; Ahn, Mi Young; Chin, Bum Sik; Kim, Young Sam; Lee, Hyukmin; Yong, Dongeun; Kim, Hyun Ok; Kim, Sinyoung; Choi, Jun Yong |
2020 |
2020-04-06 |
NONCOMM |
Y |
PMC7152526 |
32281317.0 |
10.3346/jkms.2020.35.e149 |
1uwir5b8 |
0.951283 |
Martinez_2004 |
|
| 2 |
Hui_D_2013 |
Adjunctive therapies and immunomodulating agents for severe influenza |
Hui, David S. C.; Lee, Nelson |
2013 |
2013-11-01 |
PMC |
N |
PMC6492653 |
24215382.0 |
10.1111/irv.12171 |
qb796dv9 |
0.922276 |
|
Hui_D_2013 |
| 3 |
Cao_W_2020 |
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019 |
Cao, Wei; Liu, Xiaosheng; Bai, Tao; Fan, Hongwei; Hong, Ke; Song, Hui; Han, Yang; Lin, Ling; Ruan, Lianguo; Li, Taisheng |
2020 |
2020-03-21 |
NONCOMM |
Y |
PMC7111600 |
|
10.1093/ofid/ofaa102 |
u3gmpklc |
0.892775 |
Asrar_Khan_2013, Annane_2008 |
|
| 4 |
Hui_D_2013 |
Adjunctive therapies and immunomodulatory agents in the management of severe influenza |
Hui, David S.; Lee, Nelson; Chan, Paul K. |
2013 |
2013-06-30 |
PMC |
N |
PMC7132367 |
23578727.0 |
10.1016/j.antiviral.2013.03.019 |
gw3ej4ow |
0.887770 |
|
Hui_D_2013 |
| 5 |
Zhang_2020 |
Effectiveness of Intravenous Immunoglobulin for Children with Severe COVID-19: A Rapid Review |
Jingyi Zhang; Yinmei Yang; Nan Yang; Yanfang Ma; Qi Zhou; Weiguo Li; Xia Wang; Liping Huang; Xufei Luo; Toshio Fukuoka; Hyeong Sik Ahn; Myeong Soo Lee; Zhengxiu Luo; Yaolong Chen; Enmei Liu; Kehu Yang; Zhou Fu |
2020 |
2020-04-22 |
BioRxiv |
Y |
|
|
10.1101/2020.04.17.20064444 |
x6eom6kh |
0.761871 |
Asrar_Khan_2013 |
|
| 6 |
Lover_2020 |
Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial (Gautret et al, 2020) |
Andrew A. Lover |
2020 |
2020-03-27 |
BioRxiv |
Y |
|
|
10.1101/2020.03.22.20040949 |
azvbl4ie |
0.761866 |
|
Chen_2020, Gautret_2020 |
| 7 |
Hui_D_2018 |
The role of adjuvant immunomodulatory agents for treatment of severe influenza |
Hui, David S.; Lee, Nelson; Chan, Paul K.; Beigel, John H. |
2018 |
2018-02-28 |
PMC |
N |
PMC5801167 |
29325970.0 |
10.1016/j.antiviral.2018.01.002 |
nrvgnsp4 |
0.723983 |
|
Hui_D_2013 |
| 8 |
van_Griensven_2016 |
The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field |
van Griensven, Johan; De Weiggheleire, Anja; Delamou, Alexandre; Smith, Peter G.; Edwards, Tansy; Vandekerckhove, Philippe; Bah, Elhadj Ibrahima; Colebunders, Robert; Herve, Isola; Lazaygues, Catherine; Haba, Nyankoye; Lynen, Lutgarde |
2016 |
2016-01-01 |
NONCOMM |
N |
PMC4678103 |
26261205.0 |
10.1093/cid/civ680 |
riw5xs3j |
0.701516 |
|
Sahr_2017, Ceylan_2013 |
| 9 |
Jean_2020 |
Treatment options for COVID-19: the reality and challenges |
Jean, Shio-Shin; Lee, Ping-Ing; Hsueh, Po-Ren |
2020 |
2020-04-04 |
PMC |
Y |
|
|
10.1016/j.jmii.2020.03.034 |
j8n06hzx |
0.694896 |
|
|
| 10 |
Konde_2017 |
Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial |
Konde, Mandy Kader; Baker, Darren P.; Traore, Fode Amara; Sow, Mamadou Saliou; Camara, Alioune; Barry, Alpha Amadou; Mara, Doussou; Barry, Abdoulaye; Cone, Moussa 3; Kaba, Ibrahima; Richard, Amento Ablam; Beavogui, Abdoul Habib; Günther, Stephan; Pintilie, Melania; Fish, Eleanor N. |
2017 |
2017-02-22 |
None |
N |
PMC5321269 |
28225767.0 |
10.1371/journal.pone.0169255 |
nup4uep3 |
0.666962 |
|
|
| 11 |
GAUTRET_2020 |
Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial |
Philippe GAUTRET; Jean Christophe LAGIER; Philippe PAROLA; Van Thuan HOANG; Line MEDDED; Morgan MAILHE; Barbara DOUDIER; Johan COURJON; Valerie GIORDANENGO; Vera ESTEVES VIEIRA; Herve TISSOT DUPONT; Stephane HONORE; Philippe COLSON; Eric CHABRIERE; Bernard LA SCOLA; Jean Marc ROLAIN; Philippe BROUQUI; Didier RAOULT |
2020 |
2020-03-20 |
BioRxiv |
Y |
|
|
10.1101/2020.03.16.20037135 |
tdlcb9bf |
0.641996 |
|
Gautret_2020, Chen_2020 |
| 12 |
Lai_S_2005 |
Treatment of severe acute respiratory syndrome |
Lai, S. T. |
2005 |
2005-09-20 |
PMC |
N |
PMC7088345 |
16172857.0 |
10.1007/s10096-005-0004-z |
7ycha90h |
0.639368 |
|
|
| 13 |
So_L_2003 |
Development of a standard treatment protocol for severe acute respiratory syndrome |
So, Loletta K-Y; Lau, Arthur CW; Yam, Loretta YC; Cheung, Thomas MT; Poon, Edwin; Yung, Raymond WH; Yuen, KY |
2003 |
2003-05-10 |
PMC |
N |
PMC7112408 |
12747883.0 |
10.1016/s0140-6736(03)13265-5 |
w0dup04b |
0.634202 |
Martinez_2004, Annane_2008 |
|
| 14 |
Gautret_2020 |
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial |
Gautret, Philippe; Lagier, Jean-Christophe; Parola, Philippe; Hoang, Van Thuan; Meddeb, Line; Mailhe, Morgane; Doudier, Barbara; Courjon, Johan; Giordanengo, Valérie; Vieira, Vera Esteves; Dupont, Hervé Tissot; Honoré, Stéphane; Colson, Philippe; Chabrière, Eric; La Scola, Bernard; Rolain, Jean-Marc; Brouqui, Philippe; Raoult, Didier |
2020 |
2020-03-20 |
PMC |
Y |
|
|
10.1016/j.ijantimicag.2020.105949 |
5o9bbspc |
0.619088 |
Borges_2013 |
GAUTRET_2020, Chen_2020 |
| 15 |
Iwabuchi_2020 |
Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: Report of three cases |
Iwabuchi, Keisuke; Yoshie, Koichiro; Kurakami, Yuichi; Takahashi, Kota; Kato, Yoshio; Morishima, Tsuneo |
2020 |
2020-04-16 |
PMC |
Y |
|
|
10.1016/j.jiac.2020.04.007 |
uuor5hck |
0.604385 |
Annane_2008 |
|
| 16 |
Sahr_2017 |
Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone |
Sahr, F.; Ansumana, R.; Massaquoi, T.A.; Idriss, B.R.; Sesay, F.R.; Lamin, J.M.; Baker, S.; Nicol, S.; Conton, B.; Johnson, W.; Abiri, O.T.; Kargbo, O.; Kamara, P.; Goba, A.; Russell, J.B.W.; Gevao, S.M. |
2017 |
2017-03-31 |
PMC |
N |
PMC7112610 |
27867062.0 |
10.1016/j.jinf.2016.11.009 |
qw638w9u |
0.600342 |
|
Ceylan_2013 |
| 17 |
Deng_2020 |
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study |
Deng, Lisi; Li, Chunna; Zeng, Qi; Liu, Xi; Li, Xinghua; Zhang, Haitang; Hong, Zhongsi; Xia, Jinyu |
2020 |
2020-03-11 |
PMC |
Y |
|
|
10.1016/j.jinf.2020.03.002 |
5367d55r |
0.599179 |
|
Cai_Q_2020 |
| 18 |
Rana_2020 |
Therapeutic Application of Chloroquine in Clinical Trials for COVID-19 |
Divya RSJB Rana; Santosh Dulal |
2020 |
2020-03-27 |
BioRxiv |
Y |
|
|
10.1101/2020.03.22.20040964 |
jc9ugexn |
0.584497 |
|
|
| 19 |
Cai_Q_2020 |
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study |
Cai, Qingxian; Yang, Minghui; Liu, Dongjing; Chen, Jun; Shu, Dan; Xia, Junxia; Liao, Xuejiao; Gu, Yuanbo; Cai, Qiue; Yang, Yang; Shen, Chenguang; Li, Xiaohe; Peng, Ling; Huang, Deliang; Zhang, Jing; Zhang, Shurong; Wang, Fuxiang; Liu, Jiaye; Chen, Li; Chen, Shuyan; Wang, Zhaoqin; Zhang, Zheng; Cao, Ruiyuan; Zhong, Wu; Liu, Yingxia; Liu, Lei |
2020 |
2020-03-18 |
PMC |
Y |
|
|
10.1016/j.eng.2020.03.007 |
8caqxfxv |
0.560076 |
Turner_1986 |
|
| 20 |
Annane_2008 |
Corticosteroids for community-acquired pneumonia: time to act! |
Annane, Djillali; Meduri, G Umberto |
2008 |
2008-07-14 |
PMC |
N |
PMC2575557 |
18638361.0 |
10.1186/cc6940 |
jlu5l668 |
0.552728 |
Asrar_Khan_2013 |
|
| 21 |
Zhou_2020 |
Interferon-a2b treatment for COVID-19 |
Qiong Zhou; Xiao-Shan Wei; Xuan Xiang; Xu Wang; Zi-Hao Wang; Virginia Chen; Casey P Shannon; Scott J Tebbutt; Tobias R Kollmann; Eleanor N Fish |
2020 |
2020-04-10 |
BioRxiv |
Y |
|
|
10.1101/2020.04.06.20042580 |
ttdzvw1s |
0.541826 |
Borges_2013 |
|
| 22 |
Koepsell_2017 |
The Role of the Laboratory and Transfusion Service in the Management of Ebola Virus Disease |
Koepsell, Scott A.; Winkler, Anne M.; Roback, John D. |
2017 |
2017-07-31 |
PMC |
N |
PMC7126423 |
27894669.0 |
10.1016/j.tmrv.2016.11.002 |
jrfbnalc |
0.521027 |
|
Ceylan_2013 |
| 23 |
Fujii_2004 |
Current concepts in SARS treatment |
Fujii, Takeshi; Iwamoto, Aikichi; Nakamura, Tetsuya; Iwamoto, Aikichi |
2004 |
2004-12-31 |
None |
N |
PMC7088022 |
14991510.0 |
10.1007/s10156-003-0296-9 |
2irhi9i2 |
0.510614 |
|
Ceylan_2013 |
| 24 |
Bonfanti_2020 |
Core warming of coronavirus disease 2019 (COVID-19) patients undergoing mechanical ventilation: protocol for a randomized controlled pilot study |
Nathaniel Bonfanti; Emily Gundert; Kristina Goff; Anne Drewry; Roger Bedimo; Erik Kulstad |
2020 |
2020-04-06 |
BioRxiv |
Y |
|
|
10.1101/2020.04.03.20052001 |
0rbgbsj8 |
0.508724 |
|
|
| 25 |
Qin_Y_2020 |
Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial |
Qin, Yuan-Yuan; Zhou, Yi-Hong; Lu, Yan-Qiu; Sun, Feng; Yang, Sen; Harypursat, Vijay; Chen, Yao-Kai |
2020 |
2020-03-05 |
PMC |
Y |
PMC7147272 |
32149773.0 |
10.1097/cm9.0000000000000791 |
vyayyk50 |
0.494734 |
|
|
| 26 |
Ceylan_2013 |
Ribavirin is not effective against Crimean–Congo hemorrhagic fever: observations from the Turkish experience |
Ceylan, Bahadır; Calıca, Aylin; Ak, Oznur; Akkoyunlu, Yasemin; Turhan, Vedat |
2013 |
2013-10-31 |
PMC |
N |
PMC7110843 |
23773242.0 |
10.1016/j.ijid.2013.02.030 |
f1zz64ld |
0.490031 |
Asrar_Khan_2013 |
|
| 27 |
SHI_C_2020 |
The potential of low molecular weight heparin to mitigate cytokine storm in severe covid-19 patients: a retrospective clinical study |
CHEN SHI; CONG WANG; HANXIANG WANG; CHAO YANG; FEI CAI; FANG ZENG; FANG CHENG; YIHUI LIU; TAOTAO ZHOU; BIN DENG; JINPING LI; YU ZHANG |
2020 |
2020-04-01 |
BioRxiv |
Y |
|
|
10.1101/2020.03.28.20046144 |
w5zxzpj7 |
0.487894 |
Borges_2013 |
|
| 28 |
Borba_2020 |
Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study) |
Mayla Borba; Fernando de Almeida Val; Vanderson Sousa Sampaio; Marcia Araujo Alexandre; Gisely Cardoso Melo; Marcelo Brito; Maria Mourao; Jose Diego Brito Sousa; djane Baia-da-Silva; Marcus Vinitius Farias Guerra; Ludhmila Hajjar; Rosemary Costa Pinto; Antonio Balieiro; Felipe Gomes Naveca; Mariana Xavier; Alexandre Salomao; Andre Siqueira; Alexandre Schwarzbolt; Julio Henrique Rosa Croda; Mauricio Lacerda Nogueira; Gustavo Romero; Quique Bassat; Cor Jesus Fontes; Bernardino Albuquerque; Claudio Daniel-Ribeiro; Wuelton Monteiro; Marcus Lacerda |
2020 |
2020-04-11 |
BioRxiv |
Y |
|
|
10.1101/2020.04.07.20056424 |
ifxm3j4y |
0.487503 |
Borges_2013 |
|
| 29 |
Zhong_2020 |
A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of α-Lipoic acid for critically ill patients with coronavirus disease 2019（COVID-19） |
Ming Zhong; Aijun Sun; Ting Xiao; Ge Yao; Ling Sang; Xia Zheng; Jinyan Zhang; Xuejuan Jin; Lei Xu; Wenlong Yang; Peng Wang; Kai Hu; Dingyu Zhang; Junbo Ge |
2020 |
2020-04-21 |
BioRxiv |
Y |
|
|
10.1101/2020.04.15.20066266 |
mvsnybbo |
0.479283 |
|
|
| 30 |
Gedalia_2007 |
Kawasaki disease: 40 years after the original report |
Gedalia, Abraham |
2007 |
2007-08-24 |
PMC |
N |
PMC7089469 |
17688844.0 |
10.1007/s11926-007-0053-7 |
dlmgvr3g |
0.463064 |
Asrar_Khan_2013, Annane_2008 |
|
| 31 |
Burns_2011 |
A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial |
Burns, Karen EA; Chant, Clarence; Smith, Orla; Cuthbertson, Brian; Fowler, Robert; Cook, Deborah J; Kruger, Peter; Webb, Steve; Alhashemi, Jamal; Dominguez-Cherit, Guillermo; Zala, Carlos; Rubenfeld, Gordon D; Marshall, John C |
2011 |
2011-03-09 |
COMM-USE |
N |
PMC3068961 |
21388549.0 |
10.1186/1745-6215-12-70 |
rxn5lges |
0.462650 |
|
Arabi_2018, Bongard_2018 |
| 32 |
Ford_2020 |
Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment |
Ford, Nathan; Vitoria, Marco; Rangaraj, Ajay; Norris, Susan L; Calmy, Alexandra; Doherty, Meg |
2020 |
2020-04-15 |
COMM-USE |
N |
PMC7158851 |
32293807.0 |
10.1002/jia2.25489 |
4obggisp |
0.451303 |
Asrar_Khan_2013 |
|
| 33 |
Chen_2020 |
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial |
Chang Chen; Jianying Huang; Zhenshun Cheng; Jianyuan Wu; Song Chen; Yongxi Zhang; Bo Chen; Mengxin Lu; Yongwen Luo; Jingyi Zhang; Ping Yin; Xinghuan Wang |
2020 |
2020-03-20 |
BioRxiv |
Y |
|
|
10.1101/2020.03.17.20037432 |
14he8n3u |
0.449249 |
|
Chen_2020, Ceylan_2013 |
| 34 |
Li_Y_2020 |
An exploratory randomized, controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI) |
Yueping Li; Zhiwei Xie; Weiyin Lin; Weiping Cai; Chunyan Wen; Yujuan Guan; Xiaoneng Mo; Jian Wang; Yaping Wang; Ping Peng; Xudan Chen; Wenxin Hong; Guangming Xiao; Jinxin Liu; Lieguang Zhang; Fengyu Hu; Feng Li; Feng Li; Fuchun Zhang; Xilong Deng; Linghua Li |
2020 |
2020-03-23 |
BioRxiv |
Y |
|
|
10.1101/2020.03.19.20038984 |
9hknw4ws |
0.431933 |
|
Chen_2020, Ceylan_2013 |
| 35 |
Picot_2020 |
Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19 |
Picot, Stephane; Marty, Aileen; Bienvenu, Anne-Lise; Blumberg, Lucille H.; Dupouy-Camet, Jean; Carnevale, Pierre; Kano, Shigeyuki; Jones, Malcolm K.; Daniel-Ribeiro, Cláudio Tadeu; Mas-Coma, Santiago |
2020 |
2020-04-04 |
PMC |
N |
|
|
10.1016/j.onehlt.2020.100131 |
tedurmyb |
0.429313 |
|
Chen_2020 |
| 36 |
Soo_Y_2004 |
Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients |
Soo, Y.O.Y.; Cheng, Y.; Wong, R.; Hui, D.S.; Lee, C.K.; Tsang, K.K.S.; Ng, M.H.L.; Chan, P.; Cheng, G.; Sung, J.J.Y. |
2004 |
2004-07-31 |
PMC |
N |
PMC7129386 |
15214887.0 |
10.1111/j.1469-0691.2004.00956.x |
a1xy2k6s |
0.409423 |
Turner_1986 |
|
| 37 |
Wang_2020 |
Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China |
Yin Wang; Weiwei Jiang; Qi He; Cheng Wang; Baoju Wang; Pan Zhou; Nianguo Dong; Qiaoxia Tong |
2020 |
2020-03-12 |
BioRxiv |
Y |
|
|
10.1101/2020.03.06.20032342 |
23mp5961 |
0.398069 |
Martinez_2004 |
|
| 38 |
Gao_W_2020 |
Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia |
Gao, Wei Zhou; Yisi, Liu; Dongdong, Tian; Cheng, Wang; Sa, Wang; Jing, Cheng; Ming, Hu; Minghao, Fang; Yue |
2020 |
2020-01-01 |
COMM-USE |
Y |
PMC7035340 |
32133159.0 |
10.1038/s41392-020-0127-9 |
x2gxgave |
0.387856 |
Annane_2008 |
|
| 39 |
Lim_J_2005 |
Amantadine in treatment of chronic hepatitis C virus infection? |
Lim, J. K.; Wooten, D.; Siegel, R.; Cheung, R. C. |
2005 |
2005-06-09 |
PMC |
N |
PMC7166758 |
16108758.0 |
10.1111/j.1365-2893.2005.00622.x |
6boi3xql |
0.384561 |
|
|
| 40 |
Tang_2020 |
Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial |
Wei Tang; Zhujun Cao; Mingfeng Han; Zhengyan Wang; Junwen Chen; Wenjin Sun; Yaojie Wu; Wei Xiao; Shengyong Liu; Erzhen Chen; Wei Chen; Xiongbiao Wang; Jiuyong Yang; Jun Lin; Qingxia Zhao; Youqin Yan; Zhibin Xie; Dan Li; Yaofeng Yang; Leshan Liu; Jieming Qu; Guang Ning; Guochao Shi; Qing Xie |
2020 |
2020-04-14 |
BioRxiv |
Y |
|
|
10.1101/2020.04.10.20060558 |
p0jht22m |
0.378544 |
Chang_2012, Gwaltney_2003 |
Chen_2020, Gautret_2020 |
| 41 |
Cao_B_2020 |
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 |
Cao, Bin; Wang, Yeming; Wen, Danning; Liu, Wen; Wang, Jingli; Fan, Guohui; Ruan, Lianguo; Song, Bin; Cai, Yanping; Wei, Ming; Li, Xingwang; Xia, Jiaan; Chen, Nanshan; Xiang, Jie; Yu, Ting; Bai, Tao; Xie, Xuelei; Zhang, Li; Li, Caihong; Yuan, Ye; Chen, Hua; Li, Huadong; Huang, Hanping; Tu, Shengjing; Gong, Fengyun; Liu, Ying; Wei, Yuan; Dong, Chongya; Zhou, Fei; Gu, Xiaoying; Xu, Jiuyang; Liu, Zhibo; Zhang, Yi; Li, Hui; Shang, Lianhan; Wang, Ke; Li, Kunxia; Zhou, Xia; Dong, Xuan; Qu, Zhaohui; Lu, Sixia; Hu, Xujuan; Ruan, Shunan; Luo, Shanshan; Wu, Jing; Peng, Lu; Cheng, Fang; Pan, Lihong; Zou, Jun; Jia, Chunmin; Wang, Juan; Liu, Xia; Wang, Shuzhen; Wu, Xudong; Ge, Qin; He, Jing; Zhan, Haiyan; Qiu, Fang; Guo, Li; Huang, Chaolin; Jaki, Thomas; Hayden, Frederick G.; Horby, Peter W.; Zhang, Dingyu; Wang, Chen |
2020 |
2020-03-18 |
None |
Y |
PMC7121492 |
32187464.0 |
10.1056/nejmoa2001282 |
h4cu63cm |
0.373353 |
|
Cai_Q_2020 |
| 42 |
Fan_L_2020 |
Medical treatment of 55 patients with COVID-19 from seven cities in northeast China who fully recovered: a single-center, retrospective, observational study |
Lichao Fan; Chang Liu; Na Li; Huan Liu; Ye Gu; Yongyu Liu; Yu Chen |
2020 |
2020-03-30 |
BioRxiv |
Y |
|
|
10.1101/2020.03.28.20045955 |
hc0za6fh |
0.367904 |
|
|
| 43 |
Ye_Y_2020 |
Guideline-based Chinese herbal medicine treatment plus standard care for severe coronavirus disease 2019 (G-CHAMPS): evidence from China |
Yong-an Ye |
2020 |
2020-04-01 |
BioRxiv |
Y |
|
|
10.1101/2020.03.27.20044974 |
4as055wh |
0.365732 |
|
|
| 44 |
Asrar_Khan_2013 |
Major advances in managing community-acquired pneumonia |
Asrar Khan, Waseem; Woodhead, Mark |
2013 |
2013-10-01 |
NONCOMM |
N |
PMC3790563 |
24167724.0 |
10.12703/p5-43 |
gj4vjldd |
0.365280 |
|
Annane_2008 |
| 45 |
Hulme_2020 |
Reply to Gautret et al. 2020: A Bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with COVID-19 |
Oliver J Hulme; Eric-Jan Wagenmakers; Per Damkier; Christoffer Fugl Madelung; Hartwig Roman Siebner; Jannik Helweg-Larsen; Quentin Gronau; Thomas Lars Benfield; Kristoffer H Madsen |
2020 |
2020-04-03 |
BioRxiv |
Y |
|
|
10.1101/2020.03.31.20048777 |
tg8kfiot |
0.317964 |
|
Lover_2020, Ceylan_2013, Gautret_2020, Chen_2020 |
| 46 |
Hooper_2008 |
Intravenous Immunoglobulins: Evolution of Commercial IVIG Preparations |
Hooper, John A. |
2008 |
2008-11-30 |
PMC |
N |
PMC7135658 |
18940573.0 |
10.1016/j.iac.2008.06.002 |
cmeszahl |
0.304944 |
|
Berger_2008 |